Published in Transplant Proc on November 01, 1997
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology (2001) 3.26
Retracted Long-term results and risk factors influencing outcome of major bile duct injuries following cholecystectomy. Br J Surg (2005) 3.06
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics (2001) 3.05
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71
Sexual segregation in ungulates: a comparative test of three hypotheses. Biol Rev Camb Philos Soc (2002) 2.34
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24
The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics (2001) 2.21
The impact of carbon dioxide pneumoperitoneum on liver regeneration after liver resection in a rat model. Surg Endosc (2009) 2.16
Specific staining of human chromosomes in Chinese hamster x man hybrid cell lines demonstrates interphase chromosome territories. Hum Genet (1985) 2.14
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Well-established nucleon resonances revisited by double-polarization measurements. Phys Rev Lett (2012) 1.99
Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology (1998) 1.98
Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy. J Hepatol (2010) 1.95
Unexpected power-law stress relaxation of entangled ring polymers. Nat Mater (2008) 1.91
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant (2012) 1.88
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant (2008) 1.86
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology (1996) 1.86
Management and outcome of patients with combined bile duct and hepatic arterial injuries after laparoscopic cholecystectomy. Surgery (2004) 1.82
Interlaboratory variation of biochemical markers of bone turnover. Clin Chem (2001) 1.82
Isolation of viruses from specimens submitted for direct immunofluorescence test for respiratory syncytial virus. J Pediatr (1986) 1.78
Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol (1990) 1.76
Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg (2008) 1.74
Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. Transplant Proc (1990) 1.71
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. Am J Transplant (2008) 1.67
C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant (2006) 1.62
Hepatocellular carcinoma in association with hepatic focal nodular hyperplasia. Acta Radiol (2006) 1.59
Exhaled nitric oxide in childhood asthma. Eur J Pediatr (1996) 1.57
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant (2013) 1.54
A theoretical approach to the question of "community control" of health services facilities. Am J Public Health (1971) 1.54
[S3-Guidelines "Exocrine pancreatic cancer" 2007]. Z Gastroenterol (2007) 1.52
Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation. Radiology (1997) 1.52
Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg (1988) 1.51
Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51
Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound. Ultraschall Med (2011) 1.50
Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization. Radiology (1998) 1.49
Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology (2000) 1.48
Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int (1996) 1.47
The laparoscopic Janeway gastrostomy. An alternative technique when percutaneous endoscopic gastrostomy is impractical. Endoscopy (2001) 1.46
Management and outcomes of haemorrhage after pancreatogastrostomy versus pancreatojejunostomy. Br J Surg (2011) 1.46
Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol (2005) 1.46
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Experiences with liver transplantation in Hannover. Hepatology (1984) 1.45
Venous complications after orthotopic liver transplantation. Clin Transplant (2000) 1.43
Discontinuation of antistreptococcal prophylaxis. A double-blind study in rheumatic patients free of heart disease. JAMA (1966) 1.42
The role of estrogens in schizophrenia gender differences. Schizophr Bull (1990) 1.41
Diagnosis of enteroceles by dynamic anorectal endosonography. Dis Colon Rectum (2000) 1.40
Introduction of laparoscopic cholecystectomy in a large teaching hospital: independent audit of the first 3 years. Br J Surg (1995) 1.40
Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg (2001) 1.40
[Simulation of a colon carcinoma: diuretic-induced ulcerative-stricturing ischemic colitis]. Dtsch Med Wochenschr (2004) 1.39
On homelessness and the American way. Am J Public Health (1986) 1.38
Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. Transplantation (2001) 1.38
Donor criteria in hepatic transplantation. Langenbecks Arch Chir (1994) 1.38
[Mesenteric artery occlusion as a rare complication of thromboangiitis obliterans]. Chirurg (2002) 1.38
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer (2007) 1.37
Constitutive activity of the light-sensitive channels TRP and TRPL in the Drosophila diacylglycerol kinase mutant, rdgA. Neuron (2000) 1.36
Clinical extracorporeal hybrid liver support--phase I study with primary porcine liver cells. Xenotransplantation (2003) 1.35
Chronic recurrent multifocal osteomyelitis in children. Pediatr Infect Dis J (1999) 1.34
mTOR inhibitors: an overview. Liver Transpl (2001) 1.32
Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization. Transplant Proc (1987) 1.30
Appointment-breaking in a general medical clinic. Med Care (1971) 1.30
Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant (2013) 1.29
Magnetic inversion symmetry breaking and ferroelectricity in TbMnO3. Phys Rev Lett (2005) 1.29
Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant (2007) 1.26
Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant (2005) 1.26
HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res Hum Retroviruses (2010) 1.26
Limitations of community control of health facilities and services. Am J Public Health (1978) 1.25
EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem (1992) 1.24
The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat. Transplantation (1992) 1.23
The last 3 months of life of cancer patients: medical aspects and role of home-care services in southern Switzerland. Support Care Cancer (1996) 1.23
Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. Gut (1996) 1.22
Regulatory peptide receptors in human hepatocellular carcinomas. Gut (1999) 1.22
Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodules. Exp Clin Endocrinol Diabetes (2009) 1.21
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis. J Med Chem (2000) 1.21
Organization, sequence and expression of the HLA-B27 gene: a molecular approach to analyze HLA and disease associations. Immunobiology (1985) 1.20
Transabdominal ligation of the thoracic duct as treatment of choice for postoperative chylothorax after esophagectomy. Dis Esophagus (2007) 1.19
Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect Immun (2001) 1.18
Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest (1992) 1.17
Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg (1994) 1.15
Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology (1992) 1.13
Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. J Med Chem (1997) 1.13